ProPhase Labs, Inc. reported that Jed Latkin, a long-time operations and finance expert, has accepted the role as COO of the parent company. Mr. Latkin, a Columbia MBA, represented the seller in the Company?s acquisition of the BE-SMART Esophageal Cancer Test. He immediately became a consultant to ProPhase to help develop its biotech assets including the BE-Smart test as the Company works toward its commercialization, as well as work on the Company?s other subsidiaries.

Mr. Latkin has been in the finance and management industry since 1996 and has worked with over 15 pharmaceutical companies over the last ten years alone. He has served as CEO, CFO or COO of multiple companies in Biotech, manufacturing, and other verticals. Mr. Latkin has also served as a board member of several key industry groups that has allowed him to build a diverse network of contacts that will help ProPhase find key partnerships over the next several years.

In his role at ProPhase he will not only serve as COO of the Company but also as the head of the newly restructured finance department.